US 11622968
Heterocyclic modulators of lipid synthesis
granted A61KA61K31/437A61K31/451
Quick answer
US patent 11622968 (Heterocyclic modulators of lipid synthesis) held by Sagimet Biosciences Inc. expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sagimet Biosciences Inc.
- Grant date
- Tue Apr 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/437, A61K31/451, A61K31/4525, A61K31/453